REG - Uniphar PLC - Notice of AGM & Annual Report

Veeva SystemsAnnouncement

07/04/2022 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220407:nRSG5051Ha&default-theme=true

RNS Number : 5051H  Uniphar PLC  07 April 2022

 

Publication of Notice of Annual General Meeting and Annual Report

 

 

Dublin, London | 7 April 2022: Uniphar plc (the "Company" or "Uniphar") wishes
to announce that it is today posting to shareholders its Notice of Annual
General Meeting ("AGM") for 2022 together with its annual report and accounts
for the year ended 31 December 2021 ("Annual Report"). The AGM will be held at
11.00 a.m. on 11 May 2022 at the offices of William Fry LLP, 2 Grand Canal
Square, Dublin 2, D02 A342.

Uniphar values the participation of its shareholders at its AGM and encourages
all shareholders to take part in the meeting either in person or by voting and
raising questions in advance. The Company acknowledges that many shareholders
will not be in a position to physically attend the meeting in person and as
such has put in place a number of measures to facilitate remote participation
by all shareholders as detailed below. In the interests of the health and
safety of all attendees we would encourage those intending to attend in person
to carry out an antigen test in advance of attending the meeting.

The Notice of Meeting, Form of Proxy, Annual Report and accounts are available
to view on the Company's website
at www.uniphar.ie/static/investors/shareholder-centre/agm/agm-2022/
(http://www.uniphar.ie/static/investors/shareholder-centre/agm/agm-2022/)
 and will be available for inspection during normal business hours on any
business day from today until the conclusion of the AGM at the registered
office of the Company.

Proxy voting can be carried out in advance of the AGM. Details of how to do so
are set out in further detail in the Notice of Meeting.

A conference call facility will be provided to allow shareholders to listen
live to the business of the AGM. Please note that you will not be able to use
this facility to vote, raise points or issues or ask questions. If you wish to
listen live to the AGM proceedings, you can register for the conference call
and receive participant log-in details
at www.uniphar.ie/static/investors/shareholder-centre/agm/agm-2022/
(http://www.uniphar.ie/static/investors/shareholder-centre/agm/agm-2022/) .
Shareholders availing of this facility should ensure to submit any votes in
advance of the meeting as it will not be possible to vote using the conference
call facility.

Shareholders are invited to submit questions in writing in advance of the
meeting either by email to companysecretary@uniphar.ie
(mailto:companysecretary@uniphar.ie) or by post to the Company Secretary,
Uniphar plc, 4045 Kingswood Road, Citywest Business Park, Co. Dublin, D24
V06K, Ireland. Questions must be received by 11.00 a.m. on 9 May 2022.
Shareholders must include their Shareholder Reference Number (as set out on
their Form of Proxy) with any question submitted.

The meeting will be held in accordance with prevailing Government COVID-19
related restrictions and public health guidance, if any. As the meeting
arrangements could change at short notice any such change will be communicated
to shareholders by way of Regulatory Information Service. The Board encourages
shareholders to check Regulatory Information Services and the Company's
website www.uniphar.ie (http://www.uniphar.ie) for any updates in relation to
the AGM. Shareholders are also encouraged to keep up to date with, and follow,
Government restrictions and public health guidance, if any, as circumstances
may change at short notice.

 

 

 

For further details contact:

 

 Uniphar                                        +353 (0) 1 428 7777

 Seamus Egan
 Head of Corporate Development & IR             investor.relations@Uniphar.ie (mailto:investor.relations@Uniphar.ie)

 Davy

                                                +353 (0) 1 679 6363
 (Joint Broker, Nominated Adviser and Euronext

 Growth Adviser)

 Barry Murphy
 Niall Gilchrist

 Lauren O'Sullivan

 RBC Capital Markets (Joint Broker)             +44 (0) 20 7653 4000

 Jonathan Hardy
 Jamil Miah
 Stifel Nicolaus Europe Limited (Joint Broker)  +44 (0) 20 7710 7600

 Matt Blawat
 Ben Maddison
 Francis North

 Q4 PR                                          +353 (0) 1 475 1444 or
 (Public Relations Adviser to Uniphar)          +353 87 235 6461
 Iarla Mongey

 

 

 

About Uniphar plc

 

Headquartered in Dublin, Ireland, the Uniphar Group is an international
diversified healthcare services business servicing the requirements of more
than 200 multinational pharmaceutical and medical technology manufacturers
across three divisions - Commercial & Clinical, Product Access and Supply
Chain & Retail. The Group is active in Ireland, the UK, the Benelux, the
Nordics, Germany, and the US.

 

The Company's vision is to improve patient access to pharmaco-medical products
and treatments by enhancing connectivity between manufacturers and healthcare
stakeholders. Uniphar represents a strong combination of scale, growth, and
profitability.

 

Commercial & Clinical

In Commercial & Clinical, the Group provides outsourced sales, marketing
& distribution solutions to multinational pharmaceutical and medical
device manufacturers. Active in Ireland, the UK, the Benelux, the Nordics,
Germany and the US, the Group is growing with its clients to provide
pan-European solutions, with a bespoke offering in the US. Uniphar has built
fully integrated digitally enabled customer centric solutions that are
supported by our highly experienced and clinically trained teams, leveraging
our digital technology and insights which allows us to deliver consistently
exceptional outcomes for our clients.

 

Product Access

In Product Access, the Group is growing two distinct service offerings: 1) "On
Demand", which are pharmacy led solutions for sourcing and supplying
unlicensed medicines to meet the needs of both retail and hospital
pharmacists; and 2) "Exclusive Access", which are manufacturer led solutions
for controlling the release of speciality medicines for specifically approved
patient populations in agreed markets. The Group currently delivers product
access solutions on a global basis.

 

Supply Chain & Retail

Uniphar is an established market leader in Ireland with c. 53% market share in
the wholesale/hospital market, supported by a network of 378 owned, franchised
and symbol group pharmacies. The business supports the diverse customer base
through the provision of strong service levels coupled with innovative
commercial initiatives. Supply Chain & Retail is an Irish only business
for the Group, although the manufacturer relationships and infrastructure are
also utilised for the benefit of Commercial & Clinical and Product
Access.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAIFMBTMTAMBJT